Creatine for Alzheimer’s — let’s separate the hype from the hope.

A new study has caused a stir in June 2025, but lead researcher Matthew K. Taylor told us: “ I don’t think I can recommend it to a patient that this is going to ultimately have some sort of cognitive influence.”

We speak to Dr. Taylor and Dr. Russell Swerdlow in this episode, discussing:

• Role of creatine in your brain, and why it matters for energy metabolism
• What the 2025 study found (and why it wasn’t designed to prove effectiveness)
• How scientific nuance gets lost in supplement hype
• Why even promising early data must be handled with care
• The vital difference between hype and hope

Dr. Russell Swerdlow, MD is Director of the University of Kansas Alzheimer’s Disease Research Center.

Dr. Matthew Taylor, PhD, RD is Associate Professor of Dietetics & Nutrition at the University of Kansas Medical Center.

Once you’ve listened to this episode, test your memory and reinforce what you learned with this crossword puzzle!